FGF19 and Glucose intolerance: Gestational diabetes mellitus (GDM) (de novo glucose intolerance in pregnancy) is a common cause of enhanced fetal insulin secretion and overgrowth (19), and has been associated with reduced maternal circulating FGF19 levels (20) and placental FGF19 expression (21), and reduced fetal insulin sensitivity (22).